Skip to content

Clinical and Genetics Study on Neurogenetic Diseases

Clinical and Genetics Study on Neurogenetic Diseases

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050834
Enrollment
Unknown
Registered
2021-09-04
Start date
2021-08-30
Completion date
Unknown
Last updated
2022-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurogenetic disease

Interventions

Neurogenetic diseases group:No

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Informed consent was obtained from the subject or a guardian with legal capacity if the subject has no or limited capacity; 2. Diagnosed as neurogenetic diseases due to highly consistence with internationally recognized diagnostic criteria or clinical manifestations of diseases with no clear diagnostic criteria.

Exclusion criteria

Exclusion criteria: 1. With severe bleeding tendency; 2. With blood-borne sexually transmitted infectious diseases; 3. Have a history of blood sickness.

Design outcomes

Primary

MeasureTime frame
Genetic features;

Secondary

MeasureTime frame
Demographic characteristics;Clinical characteristics;

Countries

China

Contacts

Public ContactCao Li

Shanghai Sixth People's Hospital

caoli@rjlab.cn+86 13472610202

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026